2JEMAI. A, SIEGEL R, XU J,et al. Cancer statistics, 2010[J]. Cancer J Clin, 2010, 60(5):277-300.
3GIOVANNUCCI E, HARLAN M, ARCHER C, et al. Diabetes and cancer:a consensus report[J]. Diabetes Care, 2010,33(7): 1674-1685.
4ATCH1SON E, GR1DI.EY G, CARREON J ,et al. Risk of cane er in a large cohort of U. S. veterans with diabetes[J]. Int JCancer,2011,128(3):635-643.
5WATERS K, HENDERSON E, STRAM O, et al, Association of diabetes with prostate cancer risk in the multiethnic cohort [J]. AM J Epidemiol,2009,169(8) :937-945.
6WANG M, HU R, WU H,et al. Cancer risk among patients with type 2 diabetes mellitus: a population-based prospective study in China[J]. Sci Rep, 2015,5 : 11503.
7LONG X, LIN S, SUN Y, et al. Diabetes mellitus and prostate cancer risk in asian countries: a Meta-analysis[J]. Asian Pac J Cancer Prey,2012,13(8) :4097- 4100.
8BARADARAN N, AHMADI H, SALEM S, et al. The protec- tive effect of diabetes mellitus against prostate cancer; role of sex hormones[J]. Prostate,2009, 69 : 1744-1750.
9RODRIGUEZ C, PATEL V, MONDUL M, et al. Diabetes and risk of prostate cancer in a prospective cohort of US men[J]. a,M J Epidemiology, 2005,161 (2) ; 147-152.
10DEFRONZO R, BONADONNA R, FERRANNIN1 E, et al. ?athogenesis of NIDDM. A balanced overview[J]. Diabetes 2are, 1992,15 (3) : 318-368.
二级参考文献7
1International Diabetes Federation. Diabetes Arias, Second edition. 2003.
2International Diabetes Federation. Diabetes Arias, Third edition. 2007.
3中华人民共和国卫生部.2007中国卫生统计纪要.
4Nathan DM, Cleary PA, Backlund JY, et al. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med, 2005,353:2643-2653.
5Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes ( UKPDS 35 ) : prospective observational study. BMJ, 2000,321:405- 412.
6Gaede P, Vedel P, Larsen N, et al. Muhifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med, 2003,348:383-393.
